The annual meeting of the PREDICTOM project (“Predictive Dementia Diagnostics and Treatment through Customisable Cognitive and Biomarker Screening”) took place in Thessaloniki (Greece), on 22 and 23 September, hosted by the Centre for Research and Technology Hellas (CERTH), the Multimedia and the Brain, Health and Virtual Reality Group. Project partners gathered for two days of productive exchange and were joined online by representatives from the PROMINENT and AD-RIDDLE projects under the triple+ IHI framework, to pro-mote collaboration and accelerate progress in dementia re-search. Breakout sessions focused on key areas including biomarkers, algorithms, platform development, public involvement and dissemination.
Clinical partners also participated in hands-on workshops on EEG, eye tracking and hearing tests. Strategic discussions on day 2 addressed, harmonisation of data across disciplines, integration of multimodal results and sustainability through the 3A approach: affordability, availability and acces-sibility. The consortium aligned on next steps for streamlining the patient journey, refining the analytics database and shaping a publication strategy. Input from the Scientific Advisory Board provided valuable guidance on ensuring long-term impact and adoption of project outcomes. As recruitment progresses and data collection advances, the project consortium is preparing for the next phase of analysis and results sharing, aiming to contribute meaningfully to the future of dementia risk prediction.
The PREDICTOM project has received funding from the Innovative Health Initiative Joint Undertaking, under Grant Agreement no. 101132356. This Joint Undertaking receives support from the European Union’s Horizon Europe research and innovation programme, COCIR, EFPIA, EuropaBio, MedTechEurope and Vaccines Europe.